PricewaterhouseCoopers Health Research Institute recently released their new report: “Action Required: The Urgency of Addressing Social Determinants of Health.” Anyone in health care eager to save on costs and create efficient medical interventions should review this report. This piece provides a review of report, highlighting the five steps PwC recommends taking to lead in social determinants of health (SDOH).
No longer limited to the wealthy pursuing cosmetic surgeries and cutting-edge treatments overseas, medical tourism has become a solution for the low-income and uninsured. 1.9 million Americans will travel outside the U.S. for medical care this year, according to Patients Beyond Borders.(more…)
Consumers are showing an increased demand for patient-centric portals with simplified transparency. More specifically, healthcare payers are seeking a convenient way to receive and review electronic health records (EHR) within the current market. With these recent developments, 68% of physicians believe they are prepared to provide quality in the midst of a changing industry, as stated by Healthcare Finance. This innovative revolution has consumers interested in technologies that will aid in managing their health.(more…)
Consumers who abandoned the Obamacare exchanges this year are entitled to a “hardship” exemption to the individual mandate penalty, CMS publicized Wednesday. This will directly affect people who chose to go uninsured or who enrolled in coverage that doesn’t comply with Obamacare protocols. This follows the agency’s April guidance that expanded the exemption to people who live in rural counties or have claims going back to 2016, but applicants still had to give a written explanation for why they required the exemption.
Today, a Texas lawsuit will be heard determining pivotal laws and regulations concerning the Affordable Care Act. Republican attorney generals, led by Texas’ Attorney General Ken Paxton, will go against the Democratic party, led by California’s Attorney General Xavier Becerra, to debate the fate of the ACA. U.S District Judge Reed O’Connor will hear both sides and determine whether the health law should be put on hold while the case is being contested. GOP Plaintiffs are looking for a “preliminary injunction” on the law.
Excellus Blue Cross Blue Shield was pleased to host the 2018 National Plan Automation Group (NPAG) Conference in picturesque Lake Placid, NY. The event showcased 4 days of interactive sessions exploring opportunities in EDI, electronic payments, health records, “HEDIS,” and the past, present, and future of authorization transactions. While NPAG sponsored a progressive networking retreat, attendees took advantage of Lake Placid Golf Club, Ausable Chasm, and an adventurous BobSled Experience.
In case you were not able to attend, here’s our recap of what was discussed:
Starting this month, NY State of Health (NYSOH) made several changes to the state’s SHOP program in an effort to give the federal tax credit to as many small businesses as possible.
In New York, 98% of businesses have fewer than 100 employees and over 40% of the workforce is employed in these small businesses. The recent changes impacting these businesses were allowed through the November 2017 rule that allows small employers to enroll directly through issuers and brokers and still receive the small business tax credits.
What happened? This morning, the department of Health and Human Services (HHS) published a proposed rule to expand the availability of short-term, limited-duration health insurance plans to increase affordable coverage options for Americans. The proposed rule…
Following yesterday’s Senate Finance Committee hearing, it appears Alex Azar, the former head of Pharmaceutical company Eli Lilly’s U.S. operation, is on track to be confirmed as the Head of the Department of Health and Human Services (HHS). If confirmed, Azar will replace Thomas Price M.D., a former congressman who served as the HHS secretary for seven months before resigning.
Despite a probe by Democrats, including that from Sen. Ron Wyden (D-Oregon), on his drug industry ties, Republicans have focused on the fact that Azar would come to the job with greater working knowledge of the sprawling agency, with its budget of more than $1.1 trillion and far-flung staff of nearly 80,000, than many of his predecessors, according to the Washington Post.